INTRODUCTION
Over 62,000 new cases of kidney cancer are expected in 2016, representing approximately 4% of all new diagnosed malignancies 1 . Small, localized lesions represent the largest increase in renal cell carcinoma (RCC) incidence rate, and almost half of the new cases of RCC are localized tumors 2 . It is thought that increased utilization of imaging modalities is responsible for the increased incidental finding of small renal masses 2 . Multiple options with comparable oncological outcomes exist for management of these lesions, including both radical and partial nephrectomy (PN) 3 , with PN being advantageous for most small lesions 4, 5 . As a result, both American and European guidelines recommend nephron-sparing surgery as standard of care for patients with T1 masses that can feasibly be resected 5 .
Improvements in preoperative imaging modalities have resulted in smaller lesions being detected, but these imaging techniques are often unable to distinguish benign lesions like oncocytoma or lipid-poor angiomyolipoma (AML) from RCC [6] [7] [8] . As with any surgical procedure, there is potential morbidity associated with PN 3 ; in patients with lesions more likely to be benign, active surveillance may be more appropriate than PN. Few studies have investigated the incidence of benign lesions after PN 7, [9] [10] [11] [12] [13] [14] [15] . Reported rates have been between 8.1%-32.6%, but the number of patients in many of these series is limited. Selected studies with >100 patients are summarized in Supplemental Table 1 .
There are few contemporary studies that investigate the benign pathology rate in larger This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
series of all patients undergoing PN for renal masses presumed to be RCC. Therefore, the purpose of this study was to investigate the incidence of benign renal lesions after PN in a single-center series of patients with presumed malignancy from preoperative imaging. Further, this study aims to investigate perioperative outcomes of patients undergoing PN and identify preoperative predictors of benign pathology.
METHODS
After approval by the Washington University Institutional Review Board, all patients undergoing partial nephrectomy between 2007 and 2015 were retrospectively identified using a consented, de-identified, prospectively maintained database. All patients were included in this study if pre-operative imaging was suspicious for malignancy, which was defined as solid enhancing masses or complicated renal cysts classified as Bosniak category III or IV 16 . For inclusion criteria for this study, all surgical events logged as "partial nephrectomy" were identified. Patient exclusion criteria included the following:
von Hippel-Landau syndrome, tuberous sclerosis, Birt-Hogg-Dubé syndrome, resection of more than one renal mass, and preoperative imaging consistent with benign lesions (e.g. lipid-rich AML, excluded calyx). The final cohort of patients underwent a single PN for a solitary renal lesion with curative intent for presumed RCC. .
Biopsy Procedure and Specimen Evaluation
All biopsies were performed preoperatively in order to help better inform management decisions. Patients receiving anti-coagulants were instructed to discontinue their medication for an amount of time appropriate for the diminution of its effects prior to biopsy. Biopsies were performed by experienced abdominal radiologists and interventional radiologists. Ultrasound (US) guidance is preferred at our institution and was used for all masses that were detectable sonographically. Computed tomography (CT) guidance was reserved for masses not well-demonstrated by US. The number of biopsy cores taken was at the discretion of the radiologist. Immediate post-biopsy imaging with either US or CT was performed to assess for perinephric hematoma formation. classified as having open procedures after conversion from laparoscopic or roboticassisted operations. The mean BMI of this patient cohort was 31.1, and the mean age was 57.5 years. Baseline patient demographics are further described in Table 1 .
Data collection
Of the 916 patients in this study, 129 (14.1%) patients revealed benign pathology upon final diagnosis (Table 1) histology underwent partial nephrectomy, and operative histology confirmed benignity.
The remaining 9 patients were managed conservatively.
The association of different preoperative variables with benign histology after surgery was then assessed in univariate analysis ( This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Perioperative outcomes between patients with benign vs. malignant histology after PN were then evaluated ( Table 4) . A total of 17 (13.4%) patients with benign histology had perioperative complications, including 6 (4.7%) patients with Clavien grade III or IV complications (Supplemental Table 2 ). There was no difference in the rate of complications between patients with benign and malignant pathology (p=0.93).
Similarly, both set of patients received perioperative blood transfusions at similar rates (p=0.24). Patients with benign histology had significantly shorter operative times (p<0.001) and less estimated blood loss (p<0.001) than patients with malignancy.
DISCUSSION
PN is the gold standard for management of renal masses ≤4 cm in healthy patients, and this is reflected in both American and European guidelines 5 . Renal masses are often found incidentally via imaging modalities 2 , and previous groups have reported rates of benign histology after PN for these masses upwards of 30%
14
. Because most previous studies are limited by low patient numbers, the aim of this study was to investigate the rate of PN is a large series of PN patients over the span of 8 years. In this study, we found an incidence of benign lesions of 14.1% in patients undergoing PN for a solitary renal lesion, and an incidence of 15.1% in renal masses ≤4 cm.
The rates of benignity vary across studies, though the results herein are similar to those in most other large-scale reports. In two different series of Japanese patients, pathologic reports revealed benign findings after PN in 8.1% and 11% of patients 7, 15 . A Interestingly, in the cohort of patients included in the present study, neither gender nor age was significantly associated with benign histology. R.E.N.A.L. score, tumor size, preoperative creatinine, and body mass index were the only characteristics independently associated with final histologic diagnosis in this study.
Because the clinical associations with benignity in our study differ from previous studies 9, 15 , we hypothesized that the reason for discrepancy was based upon the distribution of This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. . Ultimately, better prognostic models will need to be disease-specific (e.g. AML and oncocytoma) and potentially include a combination of clinical and radiographic parameters, as well as urinary biomarkers and biopsy pathology. Such models may help reduce the number of patients undergoing unnecessary PN for benign lesions.
Potential selection bias is a limitation of this study due to the retrospective design. The indications for elective PN at our institution are similar to the indications reported by other institutions. However, it is possible that patients with small renal masses, elevated creatinine, and higher BMIs were considered more preferentially for preoperative biopsy, active surveillance, or image-guided ablation. Renal biopsy can influence management decisions, and in our practice, only 10% of patients with a benign biopsy underwent partial nephrectomy. However, given the overall low number of patients biopsied relative to the total number of partial nephrectomies performed, it is unlikely This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
